疑似或确诊青光眼患者接受单眼玻璃体腔注射治疗渗出性AMD后视网膜神经纤维层变薄速率
本研究为回顾性对比队列研究,纳入53例单眼渗出性AMD且双眼确诊或疑似青光眼并接受单眼玻璃体腔注射的患者。注射后眼压升高、注射频率及总注射次数与RNFL变薄加速无关。
要点
- 注射眼与未注射眼RNFL变薄速率无显著差异。
- 注射后眼压升高、注射频率及次数未显示与RNFL变薄相关。
- 在确诊青光眼亚组中,注射对RNFL变薄的影响仍不显著。
核心结论
- 在疑似或确诊青光眼的渗出性AMD患者中,接受玻璃体腔注射眼的RNFL变薄速率与未注射的对侧眼无显著差异。
研究设计与样本
- 回顾性对比队列研究,纳入53例单眼渗出性AMD且双眼确诊或疑似青光眼并接受单眼玻璃体腔注射的患者。
- 纳入标准为至少3次RNFL OCT扫描和至少6次注射,采用线性混合模型评估RNFL变薄速率。
主要发现
- 注射后眼压升高、注射频率及总注射次数与更快的RNFL丢失无关。
临床怎么用
- 对于合并或疑似青光眼的渗出性AMD患者,单眼玻璃体腔注射未显示出加速RNFL变薄的明确证据。
局限性
- 本研究为回顾性设计,样本量有限,可能不足以检测微小差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study evaluated whether the rate of retinal nerve fiber layer (RNFL) thinning is faster in eyes receiving intravitreal injections than in fellow uninjected eyes among patients suspected of having or confirmed to have glaucoma and exudative age-related macular degeneration (AMD). DESIGN: Retrospective comparative cohort study. METHODS: Patients with a diagnosis of unilateral exudative AMD and confirmed to have or suspected of having glaucoma in both eyes receiving unilateral intravitreal injections were identified. Those with ≥3 RNFL optical coherence tomography scans and ≥6 injections were included in the study. Rates of RNFL thinning in the injected eye versus the uninjected eye were estimated using linear mixed models. The main outcome measurement was the differences in rates of RNFL thinning in the injected versus the fellow uninjected eye. The effects of postinjection elevation of intraocular pressure (IOP), injection frequency, and number of injections were also evaluated. RESULTS: A total of 53 patients met the inclusion criteria, receiving 26.4 ± 15.9 intravitreal injections. The average rate of RNFL thinning in uninjected eyes was -0.620 μm/year (P = .029). Injected eyes had an additional incremental loss of -0.385 μm/year, but this value was not statistically significant (95% confidence interval [CI]: -1.147 to 0.379 μm/year; P = .324). Subgroup analysis with only glaucoma patients (n = 33) also demonstrated a nonsignificant effect of injections (-0.568 μm/year; 95% CI: -1.454 to 0.319 μm/year; P = .212). Postinjection IOP elevation, injection frequency, and total number of injections were not associated with faster RNFL loss. CONCLUSIONS: Among exudative AMD patients with glaucoma or suspected of having glaucoma, the rate of RNFL thinning in eyes receiving intravitreal injections did not significantly differ from that of fellow uninjected eyes.
引用
- Swaminathan SS, Kunkler AL, Quan AV, et al. Rates of RNFL Thinning in Patients with Suspected or Confirmed Glaucoma Receiving Unilateral Intravitreal Injections for Exudative AMD. Am J Ophthalmol. 2020. PMID: 33359714. doi:10.1016/j.ajo.2020.12.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。